Disgusted Tucker Carlson turns on Republican party after congressman calls for Gaza to be 'nuked'
Tucker Carlson said he's not sure he can support the Republican party after a Florida congressman called for Gaza to be nuked.
Congressman Randy Fine, who was recently elected to replace Mike Waltz in Florida as the preferred candidate of President Trump, made the jaw dropping comments in a Fox News interview last month.
He said: 'In World War 2 we did not negotiate a surrender with the Nazis, we did not negotiate a surrender with the Japanese.
'We nuked the Japanese twice in order to get unconditional surrender. That needs to be the same here in Gaza.
'There is something deeply wrong with its culture and it needs to be defeated.'
The extraordinary comments sparked widespread outrage and prompted a response from Hamas itself - the terror cell and de facto government in Gaza.
Carlson, speaking on his podcast alongside Glenn Greenwald, said he was so taken aback by the comments that he initially thought they couldn't have been made by a real politician.
'I text a friend of mine in Congress,' Carlson said. 'This is a person who I confirmed is a real person. I didn't believe it at first... I didn't believe he was really a member of Congress.'
Congressman Randy Fine, who was recently elected to replace Mike Waltz in Florida as the preferred candidate of President Trump (pictured together), made the jaw dropping comments in a Fox News interview last month
'It's evil. How can you say something like that and not get expelled from Congress? How can that person still be in the Republican party?'
Carlson went on to say that Fine's comments had made him question whether he could remain loyal to the Republican party.
'I don't know if I can support a party with someone like Randy Fine... that's so disgusting.
'So we're gonna nuke Gaza because of its culture? We're going to kill everyone because we don't like their culture?' he repeated incredulously.
'There are Christians in Gaza. Muslims in Gaza. To say there is some Gazan culture that's cohesive.'
Carlson has been one of MAGA's most outspoken and high profile supporters, particularly loyal to Trump.
But Fine is a Jewish Trump-backed pick who won 83 percent of the Republican primary vote after the president's endorsement.
'Randy Fine has my Complete and Total Endorsement. RUN, RANDY, RUN!' Trump said at the time.
Fine has a history of bad blood with Florida Gov. Ron DeSantis, who has also fallen out with Trump after running against him in the Republican presidential primary.
'I think these are voters who didn't like Randy Fine, but who basically were like, ''You know what? We're going to take one for the team. The President needs another vote up there. And so we're going to do it'',' DeSantis said of Fine's victory, going on to describe him as a 'squish.'
And the Florida congressman doubled down in his attacks on Gaza on Monday, sharing a post to Instagram in the wake of the anti-Israel terror attack in Boulder, Colorado.
'We need to not be afraid to call evil by its name. Palestinianism,' he wrote.
Fine added that his Jewish sons had been picked on at school since the October 7, 2023 Hamas attack on Israel which led to the current conflict in the region.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
30 minutes ago
- Reuters
Pressure mounts on Netanyahu as opposition moves to dissolve parliament
TEL AVIV, June 4 (Reuters) - A member of Israel's right-wing coalition threatened to quit the cabinet on Wednesday and support an opposition motion to dissolve parliament tabled for next week, piling pressure on Israeli Prime Minister Benjamin Netanyahu. Latest opinion polls suggest that Netanyahu's coalition would lose power if an election was held today, with many voters unhappy over the continued war in Gaza prompted by the attack by Hamas militants on southern Israel in October 2023. United Torah Judaism, one of two ultra-Orthodox parties in the coalition, said it would withdraw from the government unless it secured last-minute concessions formalising an exemption for ultra-Orthodox men from military service. The opposition party Yesh Atid, led by former prime minister Yair Lapid, put forward a parliamentary vote for next week to topple the government, even as the Israeli army continues battling Hamas in the Gaza Strip. It would require the support of 61 out of the 120 members of the parliament to succeed. "This Knesset (parliament) is finished. It has nowhere to go," Lapid said. Netanyahu, Israel's longest-serving prime minister, has remained silent on the looming crisis. A spokesperson for United Torah Judaism leader Yitzhak Goldknopf told Reuters the party would vote in favour of dissolving parliament unless exemption legislation was passed. With a week until the vote, Netanyahu and his allies still have time to negotiate over an issue that has dogged the coalition for months. A source close to the government said, on condition of anonymity, that negotiations within the coalition were continuing. Netanyahu's coalition of secular right-wing and ultra-Orthodox parties holds an 8-seat majority in parliament. United Torah Judaism has 7 seats while its ally, Shas, the other ultra-Orthodox party, has 11. The coalition is sharply divided over whether young ultra-Orthodox men who are studying in religious seminaries should be exempt from mandatory military service. Failing to pass an exemption risks a walkout by ultra-Orthodox lawmakers, while approving it could trigger a protest exit by secular parties. Coalition member Ohad Tal of Bezalel Smotrich's Religious Zionism party criticized Goldknopf for threatening to trigger elections and called on the ultra-Orthodox lawmaker to resign. He urged others to negotiate a new arrangement but that a blanket exemption from military service could no longer stand. Former Knesset member Ofer Shelah said Netanyahu was likely betting the ultra-Orthodox lawmakers were bluffing, given the polls suggested they faced defeat in any early election. In March, ultra-Orthodox lawmakers threatened to bring down the government over the same issue, but time passed without any action. Resentment over the informal exemption given to religious seminary students is growing and lawmakers from the ruling coalition and opposition ranks say it is no longer tenable. Netanyahu won election in 2022 and does not have to return to the polls until 2026. Historically, few Israeli governments serve a full term. He has faced widespread criticism for failing to prevent the surprise October 2023 Hamas attack that killed roughly 1,200 people, and is facing growing calls from protesters and families of hostages still held in Gaza to end the war to secure their release. But some in his coalition say the war must continue until Hamas is eradicated. Political analysts say that the ultra-Orthodox lawmakers could simply quit the government to protest their failure to secure concessions, without toppling the ruling coalition.
The Independent
30 minutes ago
- The Independent
Millions of doses of ‘pandemic-ending' HIV jab at risk over Trump's aid cuts
Professor Linda-Gail Bekker recalls having 'shivers' when she found out that not one single woman given a revolutionary new jab in her medical trial had caught HIV. She told a global Aids summit last year that she 'literally burst into tears.' Now, she tells The Independent, that emotion has turned into an 'acute sense of despair '. The funding to get lenacapavir – a twice-yearly preventative jab that has been described as the nearest thing we have to an HIV vaccine – out to at least two million people around the globe is in question amid the turmoil accompanying Donald Trump decision to slash US aid spending. Lenacapavir stops HIV from replicating meaning that, as long as someone is on the drug, they are almost totally protected from developing the virus if they are exposed to it. Prof Bekker's study found a 96 per cent reduction in HIV overall - but in the arm of the trial looking at women and adolescent girls, there were no infections at all. Global funders, led by Pepfar and the Global Fund, in December promised to secure enough doses of the jab to protect at least two million people over three years. Its manufacturer Gilead says it will sell these at no profit, though it has not made the cost of a dose public. Gilead has also signed agreements with six pharmaceutical companies in India, Pakistan, Egypt, and the US to allow them to make generic versions of the drug in order to increase supply and drive down the cost of the jab. A significant chunk of the money to fund the doses of lenacapavir was set to come from the US-led global Aids response programme, the US President's Emergency Plan for Aids Relief (Pepfar). But this funding, and the future of Pepfar itself, is now uncertain. 'In all of the excitement [of the trial results] we were thinking, well, what do you do with [the] doses? What's the best way to use it?' Prof Bekker says. 'Suddenly, that is very much up in the air'. The other main funding source, the Global Fund to Fight AIDS, Tuberculosis and Malaria has said that it still aims to fund the doses of lenacapavir. Speaking to The Independent, however, Global Fund executive director Peter Sands tempers this by saying the success of his organisation's funding round coming up later this year would, 'determine how much scope we have for this'. The US was the Global Fund's biggest donor. Sands says that while he would 'love to say' the Global Fund could fill the gap, this would be contingent on how much money is raised from governments and private donors. "Despite all the uncertainties both around Pepfar and our own future funding, we are still very keen to deliver on the ambition,' Sands says. But, more funding than they have currently been pledged will be needed to, 'realise the full potential of lenacapavir'. At the World Health Organisation (WHO)'s annual decision-making meeting which concluded late last month, the United Nations' Aids agency (UNAIDS) called for 'urgent action to avoid millions of avoidable HIV infections and Aids-related deaths,' saying this included, 'access to long-acting injectables for HIV prevention which are almost 100 per cent effective at preventing infections' – a nod to lenacapavir. 'A missed opportunity' Prof Bekker played a crucial role in trialling the jab in eight countries including her home country of South Africa, and she was on the brink of seeing that breakthrough rolled out – it could have been in people's arms by the end of this year. Long-acting jabs like lenacapavir are not only about protecting individuals, they are a crucial part of ending the Aids pandemic, Prof Bekker explains. 'A six-monthly injectable is as close as we can get at this moment to a vaccine,' Prof Bekker says. Just like with a vaccine, it can help keep whole populations safe by stopping vulnerable people from catching the virus and then potentially spreading the virus to more people. 'You finally have something that could actually bring us to a conclusion [of the Aids crisis]. 'It just feels like such a calamitous missed opportunity,' she says. Overcoming stigma A daily preventative medicine – a combination of two drugs known collectively as pre-exposure prophylaxis (PrEP) – is already available and is very effective. But people without reliable access to healthcare find it harder to maintain a regime that involves regular pills. Girls, young women and LGBT+ people in Southern Africa can also face questioning from family members if they have packets of daily pills in their homes which indicate they are sexually active, and it can put women in relationships at higher risk of domestic violence. A six-monthly jab on the other hand can be maintained more discreetly and with less user error. Offering lenacapavir to young women – among the hardest to reach with HIV prevention - when they book into prenatal care can also prevent them from passing the virus onto their children. 'That is a good use of money, right?' Prof Bekker says. 'You're saving two infections; one of them a lifelong infection in a child that will need antivirals for the next 70 to 75 years'. 'They are young people in front of us. We can introduce them to Republican Congressmen if needed'. A State Department spokesperson said: 'Pepfar continues to support lifesaving HIV testing, care and treatment, and prevention of mother to child transmission services approved by the Secretary of State. 'As directed by the Secretary of State all other Pepfar-funded services are being reviewed for assessment of programmatic efficiencies and consistency with United States foreign policy. Pepfar, like all assistance programmes, should be reduced over time as it achieves its mission.' Ending Aids Figures previously reported by The Independent suggest Trump's slashing of foreign aid has derailed the projected end of the Aids pandemic and could lead to four million extra deaths by 2030. The latest global figures show there were 1.3 million new HIV infections and roughly 630,00 people dying from Aids around the world in 2023. Regardless of the cuts, before any doses can be made available, the drug has to be approved by regulators. The US Food and Drug Administration (FDA)'s decision is understood to be on track to approve the preventative jab on 19 June, followed by other national medicines regulators and the WHO. Before the cuts, an FDA approval would have marked the moment it would be full steam ahead to roll lenacapavir out to the people who need it most. But those approvals won't count for much if the money to pay for the drug and get it out to the people who need it doesn't materialise, as Prof Bekker fears. 'It does feel like this thing that could help us end the epidemic sooner is suddenly receding in the chaos'.
The Independent
30 minutes ago
- The Independent
Friends actor warns Jewish people ‘the cavalry aint coming' after Colorado flamethrower attack
Friends actor Michael Rapaport has warned Jewish people that 'the cavalry ain't coming' after a horrific flamethrower attack at a pro-Israel march in Boulder, Colorado. On an episode of his podcast 'I Am Rapaport' that was released Tuesday, Rapaport, who played Phoebe Buffay's boyfriend Gary on the hit TV show Friends, spoke out about the terror attack last Sunday that left 12 demonstrators injured. 'What's going on in the world for Jewish people, what's going on in the world for people that support and believe in the right of the existence of Israel, a.k.a. Zionists, is frightening,' Rapaport said. Rapaport, who is Jewish, said, 'I don't think I have felt scared since October 7,' referring to Hamas' deadly attack on Israel in 2023. The actor said that he has spoken out for other groups in their time of need, but now no one is supporting him and his fellow Jewish and Zionist people. 'I put a f***ing black square [on social media] like a f***ing a****** during Black Lives Matter. Don't you feel like an a****** now? For putting up a black square during Black Lives Matter when nobody is coming and saying anything on our behalf.' Rapaport said that he's been traveling all over the U.S. and in Israel as an outspoken supporter of Israel for the last '500 days.' 'All the time people go, 'Why isn't anyone saying anything … Do you feel ignored, do you feel alienated?' Yes, yes, yes,' he said. The actor continued: 'I'm telling you something, Jewish people, the cavalry ain't coming. The cavalry is not coming for us. They don't give a f***.' 'It's sad, it's frustrating. You feel used. You feel manipulated. You feel like a sucker. I feel like it, too!' he added. Mohamed Sabry Soliman, a 45-year-old Egyptian national, was arrested and charged with a federal hate crime and 16 counts of attempted murder in connection with the attack. He had entered the US on a visa that expired two years ago and was subsequently granted work authorization, which expired last March. The suspect told authorities he spent a year planning the attack and specifically targeted a 'Zionist group.' Witnesses reported Soliman shouting 'Free Palestine!' before firing a 'makeshift flamethrower' and Molotov cocktails, per the FBI. The victims were participating in a 'Run For Their Lives' event in support of the release of the remaining hostages held in Gaza.
